Month: June 2016

Small business owners are invited to a free small business check-up July 14 to learn about insurance, accounting, preparing for the unexpected and legal issues small businesses often face. All attendees will receive a free business resiliency workbook. The check-up, sponsored by the Delaware Small Business Development Center and the U.S. Small Business Administration and…

Courtney W. Stevenson, Delaware State University’s oldest living graduate at age 102, was honored with a birthday party at Whatcoat United Methodist Church of Dover earlier this month. Stevenson, who turned 102 on June 12, graduated in 1944 from the then-State College for Colored Students with a bachelor of science in home economics. She later…

Audubon resident Jose Luna, culinary team member at the LongHorn Steakhouse in Bear, was recently recognized as the regional winner of the company’s Steak Master Series competition. This honor is bestowed upon the top performing culinary team members in the company. He is one of just 60 team members from LongHorn Steakhouse to achieve this…

Associated Press House lawmakers have passed legislation endorsing a proposed school redistricting plan for Wilmington while not committing any funding for the effort. The measures cleared the Democrat-led House with no Republican support Wednesday. Wilmington is currently served by four school districts. The redistricting plan centers on moving inner-city students from the Christina district and…

Delaware Technical & Community College formally inaugurated Mark T. Brainard as its fifth president June 9. The ceremony, held at the Chase Center on the Riverfront, was held in conjunction with the college’s year-long 50th anniversary celebration. The event featured alumni, students, delegates from other colleges and universities, staff, counselors, librarians, faculty, administrators, past presidents,…

The Food and Drug Administration has granted breakthrough therapy designation for ruxolitinib — Incyte Corporation’s treatment for patients with acute graft-versus-host disease. The drug, trademarked Jakafi, is the first approved treatment available for patients with GVHD. GVHD is an often fatal complication from stem cell transplants where the transplanted immune cells attack the patient’s body.The…